
This zzso zzso study was designed to evaluate the quality of life zzso of cancer patients receiving new zzso zzso zzso was measured using a linear analog self assessment scale zzso Cancer patients who received a phase I agent zzso zzso zzso had no significant changes in any of the individual zzso zzso overall zzso zzso zzso zzso or performance status zzso zzso zzso following one course of phase I zzso However, patients who were not eligible for entry on a phase I protocol and who received supportive care zzso zzso 10) experienced significant decreases in overall zzso zzso zzso zzso and performance status zzso zzso zzso after 1 month of zzso This pilot study suggests that participation in phase I trials does not adversely affect one's zzso 

